Patents by Inventor Richard K. Frank

Richard K. Frank has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11932851
    Abstract: Antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon 44 skipping are described.
    Type: Grant
    Filed: December 22, 2020
    Date of Patent: March 19, 2024
    Assignee: Sarepta Therapeutics, Inc.
    Inventors: Richard K. Bestwick, Diane Elizabeth Frank
  • Patent number: 5435990
    Abstract: A group of functionalized macrocyclic polyaminocarboxylate chelants that form complexes with rare earth-type metal ions are disclosed. The complexes, covalently attached to an antibody or antibody fragment, can be used for therapeutic and/or diagnostic purposes for cancer.
    Type: Grant
    Filed: October 15, 1992
    Date of Patent: July 25, 1995
    Assignee: The Dow Chemical Company
    Inventors: Roberta C. Cheng, William A. Fordyce, William F. Goeckleler, William J. Kruper, Jr., Richard K. Frank, Joseph R. Garlich, Garry E. Kiefer, Kenneth McMillan, Jaime Simon, David A. Wilson, Sharon Braughman
  • Patent number: D271130
    Type: Grant
    Filed: June 25, 1979
    Date of Patent: October 25, 1983
    Inventors: Richard K. Frank, Gerald L. Quimby